Viewing Study NCT02077166


Ignite Creation Date: 2025-12-24 @ 4:17 PM
Ignite Modification Date: 2026-02-18 @ 12:08 AM
Study NCT ID: NCT02077166
Status: COMPLETED
Last Update Posted: 2022-02-04
First Post: 2014-02-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor:
Organization: